,

Buy Skyrizi (Risankizumab) Online

5.00 out of 5

  • DISEASE INDICATIONS: Psoriasis
  • MANUFACTURER: AbbVie Ltd
  • USAGE: Subcutaneous
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
  • Therapeutic Goods Administration (TGA)
Skyrizi (risankizumab) is a prescription medication for moderate to severe plaque psoriasis in adults. Administered via subcutaneous injection, Skyrizi improves the patient's quality of life by reducing scaly and itchy patches on the skin and slowing down the progression of the disease.

From $14,905.00
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist